Skip to content
Joint Surface Lesions
Agili-C™
Clinical Study
Publications
Videos
News
Loading...
Latest News & Events
News
monimono
2018-10-11T14:12:02+00:00
3
2022
FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects
March 30, 2022
8
2021
CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects
August 3, 2021
10
2020
CartiHeal Receives FDA “Breakthrough Device Designation” for the novel Agili-C Implant
October 12, 2020
07
2020
Bioventus Makes $15 Million Equity Investment in CartiHeal with an Agreed Option Structure to Acquire Company Upon Milestone Achievements
July 17, 2020
12
2019
CartiHeal announces enrollment completion for the Agili-C™ clinical study
December 20, 2019
12
2019
CartiHeal Announces Positive Interim Analysis Results of Agili-C™ IDE Study
December 10, 2019
10
2019
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Maryland
October 16, 2019
08
2019
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Texas
August 29, 2019
08
2019
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures at Hospital for Special Surgery (HSS), New York, NY
August 7, 2019
06
2019
CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA
June 12, 2019
06
2019
CartiHeal’s Agili-C™ Implant Enhances In-vitro Osteogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells
June 2, 2019
05
2019
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures in the US West Coast
May 8, 2019
05
2019
First Patient in New England Treated With the Agili-C™ Implant at CartiHeal’s Pivotal Study
May 2, 2019
03
2019
The 150th Patient in CartiHeal’s Pivotal Study Was Operated on in Tel Aviv, Israel
March 10, 2019
